Adcis Groupe Evolucare - Photo Entreprise

AI-Powered Corneal Graft Assessment for Eye Banks and Transplantation Centers

KerifAI

Innovation Award Winner – Étoiles de l’Europe
Designed for Eye Banks & Transplant Centers
AI-Powered Corneal Graft Assessment

Every donor cornea matters. Assessing graft quality accurately and consistently is essential to maximize the availability of transplantable tissues and improve patient outcomes. Yet current evaluation methods often rely on manual observations, subjective interpretations, and time-consuming workflows.

KerifAI leverages artificial intelligence and computer vision to automate the assessment of donor corneas, providing objective, reproducible, and quantitative measurements that support eye banks and transplantation professionals in making more informed decisions. Developed through a collaboration between the Rouen University Hospital Cornea Bank, EFF’INNOV Technologies, and ADCIS, KerifAI brings together expertise in medicine, research, and AI to modernize corneal tissue evaluation.

Transform donor cornea images into objective quality indicators and optimize transplant opportunities.

Improve Tissue Qualification. Reduce Waste. Increase Transplant Opportunities.

KerifAI helps organizations :

  • Standardize corneal graft assessment
  • Generate objective and reproducible measurements
  • Support tissue qualification decisions
  • Reduce operator variability
  • Increase confidence in graft evaluation
  • Optimize eye bank workflows
  • Improve traceability and reporting
  • Support better patient outcomes

Designed for Corneal Specialists, Researchers and Industry

KerifAI combines advanced image analysis, artificial intelligence, and ophthalmology expertise to simplify graft assessment.

Key Capabilities

  • Automated corneal image analysis
  • AI-powered tissue quality assessment
  • Objective graft qualification support
  • Quantitative reporting
  • Standardized evaluation workflows
  • High-throughput tissue screening
  • Reproducible measurements
  • Long-term traceability of assessments
  • Decision-support tools for eye banks
  • Integration into clinical and research workflows

The result is a faster, more reliable, and more scalable evaluation process for donor corneas.

Who Benefits from KerifAI?

Eye
Banks

Improve tissue qualification processes and maximize the use of available donor tissues. 

Corneal
Transplant Centers

Access more objective tissue quality information to support transplantation decisions. 

Clinical
Research Teams

Generate standardized quantitative data for corneal research programs. 

Pharmaceutical
Companies & CROs

Use validated imaging biomarkers in corneal disease and transplantation studies. 

From Corneal Imaging
to Better Patient Outcomes

KerifAI was created with a simple objective: use artificial intelligence to improve corneal transplantation. By providing accurate and reproducible tissue assessments, the solution helps eye banks optimize graft selection, improve operational efficiency, and support better outcomes for patients waiting for a cornea transplant.

From donor tissue evaluation to transplantation readiness, KerifAI transforms image analysis into actionable clinical intelligence.

Why Choose KerifAI ?

  • AI-powered graft assessment
  • Objective and reproducible tissue evaluation
  • Designed with leading corneal experts
  • Optimized for eye banks
  • Quantitative quality indicators
  • Improved workflow efficiency
  • Better support for transplantation decisions
  • Award-winning healthcare innovation

Real-World Applications

  • Donor Cornea Qualification
  • Eye Bank Quality Control
  • Corneal Tissue Evaluation
  • Transplant Readiness Assessment
  • AI-Assisted Graft Analysis
  • Corneal Research Programs
  • Clinical Study Endpoints
  • Digital Transformation of Eye Banks

Reduce Tissue Waste.
Increase Transplant Opportunities.

Scroll to Top